Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
---|
01/26/2011 | CN101954024A Traditional Chinese medicament for treating diabetic foot |
01/26/2011 | CN101954001A Traditional Chinese medicinal pills for treating coronary disease and angina pectoris, preparation method thereof and detection method thereof |
01/26/2011 | CN101954000A Traditional Chinese medicinal dispersible tablets treating coronary disease and angina pectoris, preparation method thereof and detection method thereof |
01/26/2011 | CN101953997A Traditional Chinese medicine capable of nourishing yin, strengthening yang, supplementing qi and nourishing blood |
01/26/2011 | CN101953991A Medicine used for curing chronic cardiac insufficiency and preparation method thereof |
01/26/2011 | CN101953978A Heart-soothing and lipid-lowering tablet medicine quality standard detecting method |
01/26/2011 | CN101953961A Nostrum for treating vasculitis |
01/26/2011 | CN101953938A Traditional Chinese medicine for treating diabetic retinopathy |
01/26/2011 | CN101953935A Qi-nourishing and blood-activating medicinal composition and preparation method, detection method and application thereof |
01/26/2011 | CN101953928A Fumigation washing medicine for treating haemorrhoids and preparation method thereof |
01/26/2011 | CN101953918A Chinese medicinal composition for treating cardiovascular and cerebrovascular diseases |
01/26/2011 | CN101953917A Chinese medicinal composition for preventing and treating cardiovascular and cerebrovascular diseases and preparation method thereof |
01/26/2011 | CN101953915A Content measuring method and discriminating method for pharmaceutical composition preparation |
01/26/2011 | CN101953913A Quality analysis method of Zhongfenghuichun capsules |
01/26/2011 | CN101953909A Medicament for treating cerebral infarction and preparation method thereof |
01/26/2011 | CN101953901A Traditional Chinese medicine composition for treating hypertension |
01/26/2011 | CN101953890A Traditional Chinese medicinal composition for curing coronary disease and heart failure and preparation method thereof |
01/26/2011 | CN101953886A Traditional Chinese medicine for treating diabetic heart disease |
01/26/2011 | CN101953885A Chinese medicament for treating diabetic coronary heart disease |
01/26/2011 | CN101953880A Method for preparing pueraria flavonid |
01/26/2011 | CN101953869A Medicinal composition for resisting myocardial ischemia and hypoxia |
01/26/2011 | CN101953868A Detection method for total saponins of tribulus |
01/26/2011 | CN101953865A Chinese medicinal composition for treating ischemic heart diseases and preparation method thereof |
01/26/2011 | CN101953862A Extracts of eleutherococcus spp., preparation process thereof and use of the same |
01/26/2011 | CN101953860A Wet tissue for relieving hemorrhoid symptom and production method thereof |
01/26/2011 | CN101953857A Compound fermented cordyceps sinensis bacterium powder (paecilomyces hepiali Cs-4 bacterium powder) composite medicine |
01/26/2011 | CN101953853A Preparation method of purified and deleaded propolis powder and propolis product |
01/26/2011 | CN101953850A Preparation method and application of oyster shell extract |
01/26/2011 | CN101953837A Felodipine sustained-release tablets and preparation method thereof |
01/26/2011 | CN101953832A Oral drug composite of beta-cyclodextrin edaravone inclusion and preparation method thereof |
01/26/2011 | CN101953831A Buflomedil hydrochloride medicinal composition used for injection |
01/26/2011 | CN101953810A Breviscapine pill |
01/26/2011 | CN101953800A Technology for producing water-soluble coenzyme Q10 and mannitol composite powder |
01/26/2011 | CN101953798A Spray drying sustained-release liquid crystal nano particles containing paeonol and preparation thereof |
01/26/2011 | CN101953793A Preparation method of fructose diphosphate sodium powder injection |
01/26/2011 | CN101953783A Preparation process of troxerutin injection |
01/26/2011 | CN101953782A Production method for dopamine hydrochloride injection |
01/26/2011 | CN101953516A Nanometer element anion far infrared antibacterial textile underwear for modern civil diseases |
01/26/2011 | CN101953319A Transgenic animal over-expressing cardiac ankyrin repeat protein as well as production method and application thereof |
01/26/2011 | CN101698069B Traditional Chinese medicine preparation for treating cervical vertigo |
01/26/2011 | CN101618161B Traditional Chinese medicine composition for treating thrombophlebitis and preparation method thereof |
01/26/2011 | CN101543476B A naringin solid dispersion and the preparation method, and the application thereof |
01/26/2011 | CN101524393B Preparation method of gypenoside |
01/26/2011 | CN101496787B Prostaglandin E1 lipid microsphere injection with charge effect and preparation method thereof |
01/26/2011 | CN101450189B Medicine for curing angiocardiopathy and cerebrovascular disease and its preparing method |
01/26/2011 | CN101433581B Pharmaceutical composition and its uses |
01/26/2011 | CN101416991B Traditional Chinese medicine preparation for treating cerebrovascular disease and preparation technique thereof |
01/26/2011 | CN101380428B Traditional Chinese medicine for treating hypotension |
01/26/2011 | CN101362738B Method for preparing cinepazide maleate |
01/26/2011 | CN101327276B Use of ball containing moschus, bear gall and antelope horn in preparing medicament for treating coronary heart disease |
01/26/2011 | CN101279018B Chinese medicine naoxueshu preparations |
01/26/2011 | CN101240014B Lipopeptid composition with physiological activity and its preparation method and application |
01/26/2011 | CN101172997B Oligopeptide or its modified compound/derivant and application thereof |
01/26/2011 | CN101141965B Pharmaceutical composition for regenerating myofibers in the treatment of muscle injuries |
01/26/2011 | CN101066259B Solid dispersion of higher fatty alcohol and its prepn |
01/26/2011 | CN101058561B Diphenylurea derivative for inhibiting protein kinase, and composition and use thereof |
01/26/2011 | CN101007798B Benzodioxole derivatives and their preparation method and medicinal uses |
01/25/2011 | US7877147 Stimulation of the sphenopalatine ganglion for treating depression |
01/25/2011 | US7875728 Hydrazonopyrazole derivatives and their use as therapeutics |
01/25/2011 | US7875727 Benzimidazole vascular damaging agents |
01/25/2011 | US7875712 inhibitors of apoptosis and IL-1 beta secretion; mediate cell apoptosis and inflammation; good cell penetration and pharmacokinetic properties; [3S/R(2S)]3-[2-(Carbazol-9-yl-2-oxo-ethyl)-pentanoylamino]-5-fluoro-4-oxo-pentanoic acid |
01/25/2011 | US7875637 Benzimidazole derivative and use as a II receptor antagonist |
01/25/2011 | US7875633 Phenylpyridone derivative |
01/25/2011 | US7875625 3-guanidinocarbonyl-2-methyl-6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridin-9-ylmethyl hydrogen sulfate, inhibitory effect on an Na+/H+ exchanger; |
01/25/2011 | US7875614 Phthalazinones |
01/25/2011 | US7875611 Ion channel modulating compounds and uses thereof |
01/25/2011 | US7875592 Sulfated oligosaccharide derivatives |
01/25/2011 | US7875585 Hematopoietic cell E-selectin / L-selectin ligand glycosylated CD44 polypeptide |
01/25/2011 | CA2490141C 1-[(indol-3-yl)carbonyl]piperazine derivatives |
01/25/2011 | CA2477714C New cinnamic acid salts, processes for the preparation thereof and use thereof as medicament |
01/25/2011 | CA2476983C Methods and compositions using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione for treatment and management of multiple myeloma |
01/25/2011 | CA2472776C Process for the manufacture of hmg-coa reductase inhibitors |
01/25/2011 | CA2468673C Compounds specific to adenosine a1 and a3 receptors and uses thereof |
01/25/2011 | CA2466234C Herbal pharmaceutical compositions for prophylaxis and/or treatment of cardiovascular diseases and the method of preparing the same |
01/25/2011 | CA2463146C Crystalline sodium salt of telmisartan and the use of same as an angiotensin antagonist |
01/25/2011 | CA2454532C Retinoid derivatives with antiangiogenic, antitumoral and proapoptotic activities |
01/25/2011 | CA2447765C 1-biaryl-1,8-napthyridin-4-one phosphodiesterase-4 inhibitors |
01/25/2011 | CA2441834C Lipid profile modulation |
01/25/2011 | CA2432582C Sulfamidothienopyrimidines |
01/25/2011 | CA2430857C Percutaneous absorption-type pharmaceutical preparation and process for producing the same |
01/25/2011 | CA2385322C A substantially cell membrane impermeable compound and use thereof |
01/25/2011 | CA2381882C Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases |
01/25/2011 | CA2369826C Therapy of cardiac insufficiency |
01/25/2011 | CA2334200C Pyrrolo[2,3d]pyrimidine compositions and their use |
01/25/2011 | CA2317455C Hydroxamic and carboxylic acid derivatives |
01/20/2011 | WO2011008996A2 Peptides whose uptake in cells is controllable |
01/20/2011 | WO2011008709A1 Apoptosis signal-regulating kinase inhibitors |
01/20/2011 | WO2011008183A1 Trimetazidine dihydrochloride-containing medication in the form of an extended-release matrix tablet (variants) and methods for preparing same (variants) |
01/20/2011 | WO2011008028A2 Functional drinking water for improving blood circulation, and method for preparing same |
01/20/2011 | WO2011008001A2 Antihypertensive composition containing a ginsenoside-enriched fraction |
01/20/2011 | WO2011007876A1 Nucleic acid molecule capable of binding to hmgb1, and use thereof |
01/20/2011 | WO2011007755A1 Angiogenesis-regulating composition and angiogenesis regulation method |
01/20/2011 | WO2011007722A1 3-substituted-2-furancarboxylic acid hydrazide derivative and pharmaceutically acceptable salt thereof |
01/20/2011 | WO2011007565A1 PREVENTION AND TREATMENT OF ANEURYSMS USING PPARγ INHIBITOR |
01/20/2011 | WO2011007091A1 Derivatives of 5,6-bisaryl-2-pyridine-carboxamide, preparation thereof, and therapeutic use thereof as urotensin-ii receptor antagonists |
01/20/2011 | WO2011007090A1 Derivatives of 5,6-bisaryl-2-pyrimidine-carboxamide, preparation thereof, and therapeutic use thereof as urotensin-ii receptor antagonists |
01/20/2011 | WO2011006984A1 Amino derivatives of dihydro-1,3,5-triazine used in the treatment of ischemia and/or reperfusion related diseases |
01/20/2011 | WO2011006983A1 Amino derivatives of dihydro-1,3,5-triazine for treating oxidative stress |
01/20/2011 | WO2011006573A1 Combination of a sodium-proton exchanger inhibitor and of a dihydro-1,3,5-triazine amine derivative |
01/20/2011 | WO2011006387A1 Process for preparing agomelatine, crystals of agomelatine and preparing process thereof |